Pain, Chronic
Conditions
Keywords
Yoga, Meditation, Yoga Philosophy, Mantra, Mind-Body
Brief summary
MBLM is a holistic therapy for people with mental disorders whose feasibility positive effects on patients with depression have already been demonstrated in clinical application and a piloted study. In the present trial, the feasibility and effect of MBLM on patients with chronic pain will be investigated.
Detailed description
MBLM expands existing concepts of mind-body medicine with ethical and spiritual concepts from the traditional Patanjali Yoga system, which can act as a coping factor on the one hand, and higher motivation and deepening of self-administered practice (mindfulness based exercises, body-oriented yoga exercises and mantra meditation). MBLM aims to establish an exercise routine in the daily lives of the participants, which leads to salutogenesis. The promotion of mental health through meditation and yoga has been well documented, also in clinical populations. The effects of meditation and yoga on addiction and pain are promising, but there is still a need for research. Furthermore, the preventive potential of the MBLM program will be examined for healthy volunteers, analogous to the already well-researched and widely used MBSR (Mindfulness Based Stress Reduction) program, which was originally also developed for patients with pain disorders. The study will be conducted as an experimental single case analysis with multiple baseline design. Randomization takes place over time instead of control groups.
Interventions
Complex 8 week Mind-Body program.
Sponsors
Study design
Intervention model description
Single Case Research (SCR), also known as single case experimenal design (SCED). This is a reserach methodology using a single unit of analysis and characterized by repeated measures over time.
Eligibility
Inclusion criteria
1. Outpatients 2. Current diagnosis of a chronic pain disorder. 3. Over 18 years old. 4. Physically able to perform simple yoga postures and sit for 20 minutes. 5. Have given your written consent to participate in the study.
Exclusion criteria
1. Psychotic symptoms 2. Acute suicidality 3. obsessive-compulsive disorder 4. Cerebro-organic diseases with clinically relevant symptoms 5. Severe multimorbidity 6. Current participation in another meditation or yoga study 7. Regular meditation or yoga practice (\> once a week in the last 6 months)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain VAS | through study completion, daily for around 3 months | Visual Analog Scale for Pain |
| Well-Being | through study completion, daily for around 3 months | The WHO-5 Well-Being Scale (WHO-5; World Health Organisation, 1998) |
| Pain medication | through study completion, daily for around 3 months | Use of pain medication |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Mind-Wandering | through study completion, weekly for around 3 months | a) Mind-Wandering Questionnaire (MWQ; Mrazek, Phillips, Franklin, Broadway, & Schooler, 2013) |
| Body awareness | through study completion, twice weekly for around 3 months | adapted from Private-Body-Consciousness-Scale (PBCS; Miller, Murphy, & Buss, 1981), Body-Awareness-Questionnaire (BAQ; Shields, Mallory & Simon, 1989) and Multidimensional Assessment of Interoceptive Awareness (MAIA; Mehling et al., 2012) |
| Emotion Regulation | through study completion, weekly for around 3 months | Difficulties in Emotion Regulation Scale (DERS; Gratz & Roemer, 2003) |
| Depression, Anxiety & Stress | through study completion, weekly for around 3 months | DASS (Nilges & Essau, 2015) |
| Pain Self Efficacy | through study completion, weekly for around 3 months | PAIN SELF EFFICACY QUESTIONNAIRE (PSEQ) M.K.Nicholas (1989) |
Other
| Measure | Time frame | Description |
|---|---|---|
| Spiritual and Religious Attitudes in Dealing with Illness | at week 0 and week 11 | SpREUK (Büssing A., 2010) |
| Distress Tolerance | at week 0 and week 11 | Distress tolerance (Simons & Gaher, 2005) |
| Trigunas - Emotion, Cognition and Health Behaviour | at week 0 and week 11 | TGS Subscales (Puta & Sedlmeier, 2014) |
| Illness Cognition | at week 0 and week 11 | Illness Cognition Questionnaire for Chronic Diseases (Evers et al., 2001) |
| Chronic Pain Self-Efficacy | at week 0 and week 11 | CPSS (Anderson et al, 1995) |
| Quality of Life | at week 0 and week 11 | WHOQol-BREF |
Countries
Germany